DCGI Issues Advisory Against Digene Gel - Eastern Mirror
NEW DELHI — Drug Controller General of India (DCGI) Rajeev Singh Raghuvanshi has issued an advisory to discontinue the use of antacid Digene Gel manufactured
Stay updated with breaking news from Cosmetics Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW DELHI — Drug Controller General of India (DCGI) Rajeev Singh Raghuvanshi has issued an advisory to discontinue the use of antacid Digene Gel manufactured
Abbott India Limited, through a letter dated August 18, intimated to DCGI regarding voluntary product recall of all batches of Digene Gel of all flavours (mint, orange, mix fruits flavour) which are within the shelf life and manufactured at Goa facility. "The impugned product may be unsafe and its use may result in adverse reaction," the DCGI letter dated August 31 said.
Abbott India said it had stopped production of all variants of Digene Gel
Drug Controller General of India (DCGI) Rajeev Singh Raghuvanshi has issued an advisory to discontinue the use of antacid Digene Gel manufactured by drugmaker Abbott India at its Goa unit.
India News: The Drug Controller General of India (DCGI) has advised doctors and healthcare professionals to educate their patients to discontinue the use of Digen